Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Amenorrhea: early-phase trial registry

3 of 7 indexed Amenorrhea trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Amenorrhea: 7 US clinical trials tracked, 3 recruiting.

Amenorrhea is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Cornell University, running 2 of these trials.

Enrollment posture brief

Registry condition amenorrhea

OPEN 3 | RECR 43% | LATE 0 | EARLY 1 | RANK #2497 | SPON 2

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Amenorrhea (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Amenorrhea

Amenorrhea lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Amenorrhea on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Amenorrhea is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Amenorrhea research.

    Cornell University accounts for 2 of 7 trials (28.6%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Amenorrhea enrolment sits around 79 participants.

    Median target enrolment is 79 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.

  4. Amenorrhea splits between interventional and observational designs.

    3 interventional and 4 observational studies make up this index (42.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Amenorrhea records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Commercial Weight Loss Program Behavioral
1 trials
Intensified Training Behavioral
1 trials
Hematopoietic Stem Cell Transplantation Procedure
1 trials
Questionnaire Behavioral
1 trials
Leuprolide Acetate Drug
1 trials
Questionnaire Other
1 trials

US sites by state

Facility locations filed on Amenorrhea trials. A trial with sites in several states counts in each.

New York 3 trials
North Carolina 2 trials
Texas 1 trials
Missouri 1 trials
Maryland 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Amenorrhea page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Amenorrhea condition card totals 7 registered trials; most-linked intervention Commercial Weight Loss Program; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.